Characterization of ligand binding to the σ1 receptor in a human tumor cell line (RPMI 8226) and establishment of a competitive receptor binding assay

Assay and Drug Development Technologies

Volumn 10, Issue 4, 2012, Pages 365-374

  Brune, Stefanie ^a   Schepmann, Dirk ^a   Lehmkuhl, Kirstin ^a   Frehland, Bastian ^a   Wünsch, Bernhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DI O TOLYLGUANIDINE; DIOXANE DERIVATIVE; GUANIDINE DERIVATIVE; HALOPERIDOL; IFENPRODIL; N ALLYLNORMETAZOCINE; PENTAZOCINE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; PRECLAMOL; PROGESTERONE; RADIOLIGAND; SIGMA 1 OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; TRITIUM; UNCLASSIFIED DRUG; WMS 0814; WMS 0824; WMS 1119; WMS 1157; WMS 1158; WMS 1801; WMS 1813; WMS 1828;

ANIMAL TISSUE; ARTICLE; ASSAY; BRAIN MEMBRANE; CELL MEMBRANE; COMPETITIVE RECEPTOR BINDING ASSAY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INCUBATION TEMPERATURE; INCUBATION TIME; LIGAND BINDING; MULTIPLE MYELOMA; NONHUMAN; RECEPTOR DENSITY; SWINE; TUMOR CELL LINE; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANIMALS; BINDING, COMPETITIVE; BLOTTING, WESTERN; BRAIN CHEMISTRY; CELL LINE, TUMOR; GUINEA PIGS; HUMANS; KINETICS; LIGANDS; PENTAZOCINE; RECEPTORS, OPIOID, DELTA; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 84865521227     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.0376     Document Type: Article

References (49)

1. Martin WR, Eades CG, Thompson JA: The effects of morphine and nalorphine like drugs in the nondependent and morphine dependent chronic spinal dog. J Pharmacol Exp Ther 1976;197:517-532.
2. Quirion R, Chicheportiche R, Contreras PC, et al.: Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci 1987;10:444-446.
3. Quirion R, Bowen WD, Itzhak Y, et al.: A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992;13:85-86.
4. Aydar, E, Palmer, CP, Klyachko, VA, Jackson, MB: The sigma receptor as a ligandregulated auxiliary potassium channel subunit. Neuron 2002;34:399-410. (Pubitemid 34465498)
5. Fontanilla D, Hajipour AR, Pal A, Chu UB, Arbabian M, Ruoho AE: Probing the steroid binding domain-like I (SBDLI) of the sigma-1 receptor binding site using N-substituted photoaffinity labels. Biochemistry (NY) 2008;47:7205-7217. (Pubitemid 351956369)
6. Hanner M, Moebius FF, Flandorfer A, et al.: Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 1996;93:8072-8077. (Pubitemid 26277167)
7. Kekuda R, Prasad PD, Fei YJ, Leibach FH, Ganapathy V: Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 1996;229:553-558. (Pubitemid 27029069)
8. Pan YX, Mei J, Xu J, Wan B-L, Zuckerman A, Pasternak GW: Cloning and characterization of a mouse s1 receptor. J Neurochem 1998;70:2279-2285.
9. Seth P, Fei Y-J, Li HW, Huang W, Leibach FH, Gnapathy V: Cloning and functional characterization of a s receptor from rat brain. J Neurochem 1998;70:922-931. (Pubitemid 28113624)
10. Prasad PD, Li HW, Fei YJ, et al.: Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 s receptor gene. J Neurochem 1998;70:443-451. (Pubitemid 28079332)
11. Lupardus PJ, Wilke RA, Aydar E, et al.: Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP. J Physiol (Lond) 2000;526:527-539. (Pubitemid 30649616)
12. Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y: Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. J Pharmacol Exp Ther 1994;269:1300-1309. (Pubitemid 24204218)
13. Johannessen M, Ramachandran S, Riemer L, Ramos-Serrano A, Ruoho AE, Jackson MB: Voltage-gated sodium channel modulation by s-receptors in cardiac myocytes and heterologous systems. Am J Physiol Cell Physiol 2009;296:C1049-C1057.
14. Meyer DA, Carta M, Partridge LD, Covey DF, Valenzuela CF: Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. J Biol Chem 2002;277:28725-28732.
15. Wu Z, Bowen WD: Role of sigma-1 receptor C-terminal segment in inositol 1, 4, 5-trisphosphate receptor activation: Constitutive enhancement of calcium signaling in MCF-7 tumor cells. J Biol Chem 2008;283:28198-28215.
16. Hayashi T, Su T-P: Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci USA 2001;98:491-496. (Pubitemid 32105069)
17. Hayashi T, Su T-P: Sigma-1 Receptor Chaperones at the ER-Mitochondrion Interface Regulate Ca2 + Signaling and Cell Survival. Cell 2007;131:596-610. (Pubitemid 350017760)
18. Guitart X, Codony X, Monroy X: Sigma receptors: Biology and therapeutic potential. Psychopharmacol (Berl) 2004;174:301-319. (Pubitemid 39044288)
19. Hellewell SB, Bruce A, Feinstein G, et al.: Rat liver and kidney contain high densities of s1 and s2 receptors: Characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol Mol Pharmacol 1994;268:9-18.
20. Vilner BJ, John CS, Bowen WD: Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995;55:408-413.
21. Wang B, Rouzier R, Albarracin CT, et al.: Expression of sigma 1 receptor in human breast cancer. Breast Cancer Res Treat 2004;87:205-214. (Pubitemid 39505937)
22. Hayashi T, Su T-P: Intracellular dynamics of s-1 receptors (s1 binding sites) in NG108-15 cells. J Pharmacol Exp Ther 2003;306:726-733. (Pubitemid 36886174)
23. Hayashi T, Su T-P: σ-1 receptor ligands: Potential in the treatment of neuropsychiatric disorders. CNS Drugs 2004;18:269-284. (Pubitemid 38526712)
24. Su T-P, London ED, Jaffe JH: Steroid binding at d receptors suggests a link between endocrine, nervous, and immune systems. Science 1988;239:219-221.
25. Su T-P, Shukla K, Gund T: Steroid binding at sigma receptors: CNS and immunological implications. Ciba Found Symp 1990;153:107-113; discussion 113.
26. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE: The Hallucinogen N, N-Dimethyltryptamine (DMT) Is an endogenous sigma-1 receptor regulator. Science 2009;323:934-937.
27. Cobos EJ, Entrena JM, Nieto FR, Cendán CM, Del Pozo E: Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol 2008;6:344-366.
28. Hashimoto K, Ishiwata K: Sigma receptor ligands: Possible application as therapeutic drugs and as radiopharmaceuticals. Curr Pharm Des 2006;12:3857-3876. (Pubitemid 44560699)
29. Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP: Sigma-1 receptor knockout mice display a depressive-like phenotype. Behav Brain Res 2009;198:472-476.
30. Colabufo NA, Berardi F, Contino M, et al.: Antiproliferative and cytotoxic effects of some s2 agonists and s1 antagonists in tumour cell lines. Naunyn Schmiedebergs Arch Pharmacol 2004;370:106-113. (Pubitemid 39222862)
31. Spruce BA, Campbell LA, McTavish N, et al.: Small molecule antagonists of the s-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res 2004;64:4875-4886. (Pubitemid 38924532)
32. Lee IT, Chen S, Schetz JA: An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones. Eur J Pharmacol 2008;578:123-136. (Pubitemid 350309585)
33. Geiger C, Zelenka C, Weigl M, et al.: Synthesis of bicyclic s receptor ligands with cytotoxic activity. J Med Chem 2007;50:6144-6153.
34. Maier CA, Wünsch B: Novel spiropiperidines as highly potent and subtype selective s-receptor ligands. Part 1. J Med Chem 2002;45:438-448. (Pubitemid 34073461)
35. Maier CA, Wünsch B: Novel sigma receptor ligands, Part 2. SAR of spiro[[2]benzopyran-1, 40-piperidines] and spiro[[2]ben-zofuran-1, 40-piperidines] with carbon substituents in position 3. J Med Chem 2002;45:4923-4930. (Pubitemid 35192782)
36. Große Maestrup E, Wiese C, et al.: Synthesis of spirocyclic s1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability. Bioorg Med Chem 2009;17:3630-3641.
37. Holl R, Schepmann D, Fröhlich R, Grünert R, Bednarski, PJ, Wünsch, B: Dancing of the second aromatic residue around the 6, 8-Diazabicyclo[3.2.2]-nonane framework: influence on s receptor affinity and cytotoxicity. J Med Chem 2009;52:2126-2137.
38. Drexler HG, Matsuo Y: Malignant hematopoietic cell lines: In vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk Res 2000;24:681-703. (Pubitemid 30495502)
39. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
40. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354. (Pubitemid 9256559)
41. Lowry OH, Rosebrough NJ, Farr AL, Randall R: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
42. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
43. DeHaven-Hudkins DL, Fleissner LC, Ford-Rice FY: Characterization of the binding of [3H] (+)-pentazocine to s recognition sites in guinea pig brain. Eur J Pharmacol Mol Pharmacol Sect 1992;227:371-378.
44. Bylund DB, Murrin LC: Radioligand binding experiments over large concentration ranges. Life Sci 2000;67:2897-2911.
45. Köhler J: Lipasen zur asymmetrischen Synthese enantiomerenreiner NMDARezeptor-Antagonisten mit 1, 3-Dioxan-Struktur und Untersuchung der Reaktionskinetik (Ph. D. thesis). Münster, Germany, 2007.
46. Holl R, Schepmann D, Grünert R, Bednarski PJ, Wünsch B: Relationships between the structure of 6-allyl-6, 8-diazabicyclo[3.2.2]nonane derivatives and their s receptor affinity and cytotoxic activity. Bioorg Med Chem 2009;17:777-793.
47. Große Maestrup E, Wiese C, Schepmann D, Brust P, Wünsch B: Synthesis, pharmacological activity and structure affinity relationships of spirocyclic s1 receptor ligands with a (2-fluoroethyl) residue in position 3. Bioorg Med Chem 2011;19:393-405.
48. Große Maestrup E, Fischer S, Wiese C, et al.: Evaluation of spirocyclic 3-(3fluoropropyl) - 2-benzofurans as s1 receptor ligands for neuroimaging with positron emission tomography, J Med Chem 2009;52:6062-6072.
49. Cheng YC, Prusoff WH: Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-3108.